Ying-Chen Claire Hou
Clinical Laboratory Director
Ying-Chen Claire Hou, PhD FACMG, is a clinical laboratory director within the Institute for Genomic Medicine at Nationwide Children's Hospital and an assistant professor at the Ohio State University College of Medicine. Her clinical and research interests focus on elucidating the genetic etiology of human disease using genomic and multi-omics methodologies for disease diagnostics and therapy. Claire received her doctoral degree in Genetics from the University of British Columbia where she performed functional screening tests to understand the crosstalk between apoptosis and autophagy. Claire completed her post-doctoral training at the Sanford Burnham Prebys Medical Discovery institute where she performed genome-wide RNAi screens to understand endoplasmic reticulum stress and delineate its association with neurodegenerative diseases. Claire completed her Laboratory Genomics and Genetics (LGG) fellowship at Washington University School of Medicine in St. Louis where she develops strong interests in cancer cytogenetics and cancer genomics.
Prior to her LGG fellowship, Claire has worked at industry positions where she was involved in the development and validation of various genomic tests, including pharmacogenomics, inherited cancer, and whole genome sequencing. During her industry positions, she was also actively involved in research activities. She published papers on a precision medicine study that integrated whole-genome sequencing, comprehensive metabolomics, and advanced imaging to understand the value and clinical impact of surveying genome-wide disease-causing genes and variants in presumed healthy adults.
Prior to her LGG fellowship, Claire has worked at industry positions where she was involved in the development and validation of various genomic tests, including pharmacogenomics, inherited cancer, and whole genome sequencing. During her industry positions, she was also actively involved in research activities. She published papers on a precision medicine study that integrated whole-genome sequencing, comprehensive metabolomics, and advanced imaging to understand the value and clinical impact of surveying genome-wide disease-causing genes and variants in presumed healthy adults.
Sessions
-
20-Mar-2025